Regional News Archives - Page 68 of 190 - Journal for Clinical Studies

Current Edition

Regional News

Pfizer recalls 2nd blood pressure med in a week, again on potential carcinogen fears

Pfizer issued a second round of Canadian recalls this week as the country’s drug regulator continues to weed out meds with an excess of potential cancer-causing impur...

9 March 2022 Regional News blood | carcinogen

Continue Reading →

Regional News

Bluebird Bio has ‘doubts’ about continuing to do business through 2022, announces CFO resignation

With two of its prized gene therapies on clinical hold and another, Zynteglo, pulled from the market in Europe seven months ago after it was approved for use, these a...

9 March 2022 Regional News bio | Bluebird

Continue Reading →

Regional News

Mallinckrodt inks $260M settlement with US to resolve Medicaid underpayment and kickbacks allegations

A month after a U.S. bankruptcy court signed off on Mallinckrodt’s reorganization plan, the company has agreed to a $260 million settlement to resolve claims by the D...

9 March 2022 Regional News

Continue Reading →

Regional News

Fresenius nets NBA All-Star and transplant recipient Sean Elliot for kidney disease campaign

For sports fans, March is synonymous with basketball. It’s also National Kidney Month. So who better to spread the word about kidney health than an NBA All-Star who t...

9 March 2022 Regional News

Continue Reading →

Regional News

Pressing for label change, vaccine giant Sanofi takes Seqirus influenza imbroglio to the FDA

Sanofi is challenging influenza rival Seqirus on the regulatory level, arguing labels for two of the CSL Limited subsidiary’s flu shots should be amended to reflect t...

9 March 2022 Regional News

Continue Reading →

Regional News

Alnylam explores the rare disease journey in a new, hard-hitting documentary

The patient voice is a powerful one when it comes to healthcare advocacy, and Alnylam has put together a new documentary that maps the often-difficult journey those s...

2 March 2022 Regional News

Continue Reading →

Regional News

Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on

Novartis is pawning off manufacturing operations on both sides of the Atlantic. First, the company has reached a deal to sell its Ringaskiddy campus near Cork, Ir...

2 March 2022 Regional News

Continue Reading →

Regional News

Merck loses another vet, this time bidding adieu to chief patient officer Gerberding

Merck & Co.’s leadership shuffle rolled on this week as another veteran of the Kenilworth, New Jersey-based pharma company telegraphed her exit for the top spot a...

2 March 2022 Regional News

Continue Reading →

Regional News

BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line

An interesting and varied group of drugs—ranging from two first-in-class cancer therapies to a treatment that removes frown lines—face target dates for potential FDA ...

2 March 2022 Regional News

Continue Reading →

Regional News

FDA says no, thank you to Xpovio’s cancer expansion bid, prompting Karyopharm to run new study

That was fast. Just three weeks after touting a late-stage clinical trial win, a defeated Karyopharm Therapeutics now says the FDA doesn’t think the data support a la...

2 March 2022 Regional News

Continue Reading →